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Aim. Research suggests that anxiety may be a common response to a cancer diagnosis,
but research is needed to examine anxiety before diagnosis. Anxiety before diagnosis may
relate to the comprehension of relevant health information or openness to potential
treatments. This study examined anxiety and these outcomes inmenwhowerewaiting to
learn of a prostate cancer diagnosis.
Objectives. One goal of this studywas to determinewhether anxietywould increase as
men came closer to learning the results of their prostate cancer biopsy. Another goal was
to test whether anxiety was associated with knowledge about prostate cancer or
openness to different treatments.
Methods. Men (N = 265)whowere facing a prostate cancer diagnosiswere surveyed at
two time points. Time 1 occurred at the time of biopsy, and Time 2 occurred immediately
before men received their biopsy result. At each time point, men reported their anxiety
about prostate cancer and their biopsy result. At Time 2, they completed a knowledge
test of information about prostate cancer and reported their openness to different
potential treatments.
Results. Anxiety symptoms increased as men came closer to learning their diagnosis.
Also, higher anxiety was associated with lower knowledge and greater openness to
particular treatments like surgery. Interactions showed that when anxiety increased
from Time 1 to Time 2, having high or low knowledge mattered less to treatment
openness.
Conclusion. Waiting for a cancer diagnosis is an important time period in which anxiety
may increase and relate to information processing and openness to treatments.
*Correspondence should be addressed to Amanda J. Dillard, Department of Psychology, Grand Valley State University, Allendale,
MI 49401, USA (email: dillaram@gvsu.edu).
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Statement of contribution
What is already known on this subject?
 Men undergoing prostate cancer screening have been found to experience high and low levels of
anxiety.
 Research has shown that negative emotions like anxiety are common following a cancer diagnosis,
but little research has examined emotions right before diagnosis.
 Anxiety has been associated with information processing and motivation to engage in preventive
behaviours.
What does this study add?
 Applies and tests a theoretical idea related to how anxietymay change as one approaches personally
relevant threatening health feedback.
 Shows relationships between changes in anxiety and knowledge in the context of waiting for actual
health feedback.
 Associates increased anxiety in the prostate cancer context with knowledge and openness to
different treatments.
Every day thousands of people wait for information about their health. The
information may range from mild (‘you have a cold’) to severe (‘you have cancer’).
While many people may experience some uncertainty while they wait for this
information, those waiting for serious diagnoses may experience great distress. For
example, research shows that the ‘waiting game’ for cancer diagnoses is associated
with the experience of intense distress including negative emotions like anxiety (e.g.,
Awsare et al., 2008; Maxwell et al., 2000; Saegrov & Halding, 2004; Scott, 1983;
Thorne, Harris, Hislop, & Vestrup, 1999). Although this distress has been
documented, we know little about its course (Poole, 1997). For example, as people
wait, do they increase in distress? Moreover, how might distress relate to other
events during this time, like the processing of relevant health information? In this
study, we investigate these questions in men who were waiting to learn of a prostate
cancer diagnosis.
When people receive a cancer diagnosis, research shows they experience a flood
of negative emotions with anxiety being particularly prevalent (Burgess et al., 2005;
Edwards & Clarke, 2004; Hughes, 1982; Linden, Vodermaier, MacKenzie, & Greig,
2012; Saegrov & Halding, 2004; Stanton & Snyder, 1993; Stark & House, 2000; van’t
Spijker, Trijsburg, & Duivenvoorden, 1997). While this research has examined
negative emotions like anxiety after a diagnosis, research is needed to examine these
emotions before a diagnosis. The phase right before a cancer diagnosis is important
because it can be one of high anxiety (e.g., Maxwell et al., 2000; Saegrov & Halding,
2004; Scott, 1983; Thorne et al., 1999), with even higher levels than compared to
after a diagnosis (Dale, Bilir, Han, & Meltzer, 2005; Fantini-Hauwel, Dauvier,
Arciszewski, Antoine, & Manouvrier, 2011; Liao, Chen, Chen, & Chen, 2008).
Assessing emotions like anxiety before diagnosis is also important because it may
relate to individuals’ processing and comprehension of relevant information. For
example, in the area of breast cancer, one study found that increased cancer anxiety
was related to biased information processing in women who had a high risk of the
disease but were not yet diagnosed (Cameron & Reeve, 2006). This information
processing could have effects on actual decisions one makes after a diagnosis
(Denberg, Melhado, & Steiner, 2006).
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Anxiety in prostate cancer diagnoses
Relative to diagnoses of breast cancer, there has been much less research on anxiety in
people facing diagnoses of prostate cancer (Dale et al., 2005). The prostate cancer
context is uniquely important because this cancer is specific to males, and research
reveals gender differences in levels of cancer-related worry and anxiety (e.g., McQueen,
Vernon, Meissner, & Rakowski, 2008). The research on anxiety in those facing prostate
cancer diagnoses has also been mixed. For example, some studies have shown that men
who are undergoing screening are no more anxious than men who have never
participated in screening (e.g., Carlsson, Aus, Wessman, & Hugosson, 2007; Essink-Bot
et al., 1998). Little to no anxiety was found even in men who have an increased risk of
prostate cancer or who have multiple screenings (Brindle et al., 2006; Carlsson et al.,
2007; also seeWade et al., 2013). However, other research has painted a different picture
(e.g., Gustafsson et al., 1995; Medd, Stockler, Collins, & Lalak, 2005). Some studies have
found that screening increases anxiety or that men avoid screening because they are
worried theywill be diagnosedwith prostate cancer (Cormier et al., 2002; Roumier et al.,
2004). In a review of the literature, Dale et al. (2005) concluded that therewere generally
high levels of anxiety in at-risk men (e.g., age of 50 years and a first-degree relative who
had been diagnosed with prostate cancer) who were undergoing screening. This finding
was observed whether anxiety was measured as a state, subclinical or clinical levels, or as
worry.
Importantly, these empirical inconsistencies may relate to the problem of measuring
anxiety at only one time point. In other words, researchers may assess individuals only at
screening but then as theywait for their diagnoses, their anxiety changes. This ideawould
fit with predictions stemming from the model of uncertainty navigation, which offers
insight into how people respond to threatening, but not yet known, information (Sweeny
& Cavanaugh, 2012). According to the model, as individuals approach uncertain,
potentially threatening health information, they will increase in anxiety. Increases in
anxiety may motivate bracing, a coping strategy in which individuals become more
pessimistic in their expectations of the potentially threatening feedback (Shepperd,
Grace, Cole, & Klein, 2005; Sweeny & Shepperd, 2007). To date, bracing has been
investigated inmostly non-health domains (e.g., Shepperd, Ouellette, & Fernandez, 1996;
Sweeny & Andrews, 2014) or hypothetical health domains (Taylor & Shepperd, 1998). In
the present study, we were not assessing bracing per se, but rather testing its underlying
mechanism – that is, will anxiety increase as people come closer to receiving an actual
threatening diagnosis?
To date, only a handful of studies have measured anxiety more than once as men wait
for a prostate cancer diagnosis. Zisman, Leibovici, Kleinmann, Siegel, and Lindner (2001)
assessed men’s anxiety about biopsy at two time points before they learned their
diagnosis. They found that anxiety peaked at the second time point, immediately before
themen learned their results. Another study found that men’s anxiety levels (as measured
by the State-Trait Anxiety Inventory) before biopsy and then again right before they
learned their results were similar with both being significantly higher thanwhen they had
decided to have a biopsy (Saracoglu, €Unsal, Taskın, Sevincok, & Zafer Karaman, 2012).
Two other studies have assessedwhether clinical anxiety (using the Hospital Anxiety and
Depression Scale) was present in men having biopsies (Awsare et al., 2008; Macefield
et al., 2009). Although clinical anxiety was not present in either study (even for menwith
higher prostate-specific antigen [PSA] levels; Macefield et al., 2009), as men approached
diagnosis, they were more likely to say waiting for results was the most stressful aspect of
the biopsy process (Awsare et al., 2008).
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In the present study, we test the basic idea that men will increase in anxiety as they
come closer to learning their cancer diagnosis.Wemeasured anxiety in terms of themen’s
intrusive thoughts about prostate cancer and their fear about the biopsy result revealing
cancer. Along with possibly replicating others’ findings (e.g., Zisman et al., 2001), we
extend the existing research by addressing the question of whether there may be
associations with this anxiety. For example, when individuals undergo a screening
process, they are given information about the screening test, the cancer, and available
treatment options should they have cancer. How might anxiety be associated with the
processing of this information? Historically, researchers have debated about hownegative
affective states influence information processing, with some experimental research
showing it leads to more careful processing (e.g., Schwarz, 2000; Schwarz, Bless, &
Bohner, 1991), and others showing it leads to less careful processing (e.g., Conway &
Giannopoulos, 1993; Lewinsohn & Mano, 1993; Raghunathan & Pham, 1999). Unfortu-
nately, this research has not examined specific negative emotions or actual health
contexts. Of the few studies of this nature, evidence is growing to suggest that higher
anxiety will be associated with lower attention and comprehension (e.g., Cameron &
Reeve, 2006; Lerman, Seay, Balshem, & Audrain, 1995). In the present study, we examine
whether anxiety is associated with participants’ knowledge of information presented in a
decision aid about prostate cancer. Examining this association in the context of waiting to
learn of a cancer diagnosis would represent a novel contribution to research on negative
emotions and information processing.
Along with information processing, anxiety may be associated with wanting to do
particular cancer treatments. Generally, research supports the notion that when people
feel worry or anxiety about cancer, they are motivated towards preventive action (e.g.,
Cameron&Reeve, 2006; Dillard et al., 2013;McCaul, Schroeder, &Reid, 1996), including
prostate cancer screening (Consedine, 2012). Although in prostate cancer, there is no one
‘best’ treatment, some treatments may be perceived as more action-oriented. For
example, surgery may be viewed as a more problem-focused approach while watchful
waiting may be viewed as a more emotion-focused approach (Pickles, Ruether, Weir,
Carlson, & Jakulj, 2007). Related to this, research suggests that more invasive treatments
for prostate cancer, like surgery, are preferred when people perceive internal and
external pressure to ‘fight’ their cancer (Chapple et al., 2002). In the present study, if
anxiety motivates an action-oriented approach to treatment, menwho havemore anxiety
may evidence greater openness to a treatment like surgery and less openness to a
treatment like watchful waiting.
Overview and hypotheses
In the present study, we examined men’s symptoms of anxiety as they waited to learn
whether they had prostate cancer. Symptoms of anxiety about prostate cancer and the
biopsy result were assessed at two time points, both occurring before the men received a
diagnosis of prostate cancer. We also examined whether anxiety at these two time points
related to the men’s knowledge of prostate cancer or their openness to different
treatments. Based on the research described above, we had three hypotheses. First, we
hypothesized that symptoms of anxiety would increase as men came closer to receiving
their diagnosis. In other words, from Time 1 (i.e., having their biopsy) to Time 2 (i.e., right
before they learned their biopsy result), men would significantly increase in anxiety.
Second, we hypothesized a negative association between anxiety and knowledge. For
example, at Time 2, men who had higher anxiety would have less knowledge of
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informationwe gave them about prostate cancer. Third, we hypothesized that anxietymay
be associated with openness to particular treatments such that higher anxiety would be
associated with a greater openness to surgery and a lower openness to watchful waiting.
Along with testing these three hypotheses, we also explored whether anxiety would
interact with knowledge to influence openness to treatments. To date, anxiety has
interacted with knowledge to influence behaviour intentions in two previous studies,
both done in the context of breast cancer (Cameron & Reeve, 2006; Dillard et al., 2013).
Both studies suggested that when anxiety about cancer is high, individuals may be less
likely to use knowledge to inform their behaviour intentions.
Method
Participants
Men (N = 1,552) facing a prostate cancer biopsy were approached to participate in this
study. Of the 1,028who agreed, 1,023 completed the Time 1 survey (99%). Of this group,
334men (33%) were later diagnosed with localized prostate cancer and therefore eligible
to complete the Time 2 survey. Of these men, 265 (79%) completed the Time 2 survey
which was just before they received their prostate cancer diagnosis from their physician,
about 1 month (M = 35.5 days) after Time 1.1
Of participants who received a diagnosis of prostate cancer, the average age was
63 years, 73% were White/Caucasian (of which 2% were Hispanic), 25% were Black/
African American, and 2% American Indian, Asian/Asian American, or of Middle Eastern
origin. Approximately 18% of the men reported a family history of prostate cancer.
Procedure
Participants were recruited from four VA Health Systems: Ann Arbor, MI, Durham, NC,
Pittsburgh, PA, and San Francisco, CA. Institutional review board approval was obtained
from all places. Clinical coordinators at the different sites identified patients who were
either going to learn about an elevated PSA level and need for a biopsy or were being
biopsied. Men completed Time 1 at either an appointment with their urologist when they
were told they needed a biopsy (n = 125) or at their actual biopsy appointment
(n = 140).2 During reception, participants provided informed consent. They then
reported their anxiety about prostate cancer and their test result. At this time point,
participants were also randomized to receive one of two decision aids to take home.3
Approximately 1 month later, at Time 2, participants completed the anxiety measures
again as well as measures that assessed their knowledge from the decision aid and
openness to treatments. Immediately after the Time 2 survey, participants received their
diagnosis result from their urologist. In exchange for participating,men received a $20 gift
card.
1 Electronic medical records were used to learn diagnoses. Only those who had cancer returned for Time 2.
2 Analyses were conducted to test whether participants who were completing the Time 1 survey at the urologist’s office when
learning a biopsy was needed versus those who were completing the survey at the time of biopsy differed in their baseline anxiety.
Analyses showed no significant differences for intrusive thoughts, Ms = 1.01 versus 1.02, F(1, 263) = 0.03, p = ns, or test-
result anxiety, Ms = 0.88 versus 1.05, F(1, 262) = 1.72, p = .19.
3One aim of this overall project was to compare two decision aids [Fagerlin et al., 2015]. Both decision aids described localized
prostate cancer, but they differed in literacy level, emphasis on shared decision-making, and inclusion of statistical information.
When controlling for type of decision aid, the association between test-result anxiety and knowledge becomes marginal,
b = .11, t = 1.68, p = .09. All of the other analyses remain the same as reported in the paper.
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Measures
Anxiety symptoms
To assess symptoms of anxiety about prostate cancer, we used five items that
participants completed as part of the Memorial Anxiety Scale for Prostate Cancer
(MAX-PC; Roth et al., 2003). The five items were combined to create a scale of
intrusive thoughts. Intrusive thoughts represent unwanted and repetitive thoughts
focused on a stressor or stressful event (Horowitz, 1986; Horowitz, Wilner, & Alvarez,
1979). Many previous studies have used intrusive thoughts to measure cancer-related
psychological distress, including some as a proxy for anxiety (e.g., Antoni et al., 2006;
Baider & De-Nour, 1997; Devine, Parker, Fouladi, & Cohen, 2003; Dupont, Bower,
Stanton, & Ganz, 2014; Johnson Vickberg, Bovbjerg, DuHamel, Currie, & Redd, 2000;
Lepore & Helgeson, 1998; Lerman et al., 1995; Macefield et al., 2010). The items were
as follows: ‘Any reference to prostate cancer brought up strong feelings in me’, ‘I
thought about prostate cancer even though I didn’t mean to’, ‘Just hearing the words
‘prostate cancer’ scared me’, ‘Other things kept making me think about prostate
cancer’, and ‘I had more trouble falling asleep because I couldn’t get thoughts of
prostate cancer out of my mind’. Participants were asked to indicate how frequently
they experienced these symptoms in the past week and response options were ‘not at
all’ (0), ‘rarely’ (1), ‘sometimes’ (2), or ‘often’ (3). The five items were averaged at
Time 1 (a = .82) and Time 2 (a = .82).
Test-result anxiety
As ameasure of anxiety about the test result specifically, we used one item from theMAX-PC
(Roth et al., 2003), ‘I am afraid that the results frommyPSA testwill show that I have prostate
cancer’. Participants could respond to this statement with the options ‘not at all’ (0), ‘rarely’
(1), ‘sometimes’ (2), or ‘often’ (3). They answered the question at Time 1 and Time 2.
Knowledge
At Time 2, participants completed a test of information that had been presented in the
decision aid they had received. The eight questions were adapted from a survey
developed for use with newly diagnosed prostate cancer patients in the state of
Michigan (Holmes-Rovner, 2005) and from a prostate cancer decision quality measure
(Sepucha et al., 2011; also see Lee et al., 2010). Many of the questions were about the
benefits and risks of prostate cancer treatments. Examples include, ‘With treatment,
about how many men diagnosed with early-stage prostate cancer will eventually die of
prostate cancer?’, and ‘For most men with early-stage prostate cancer, how much
would waiting 4 weeks to make a treatment decision affect their chances of survival?’.
All questions were multiple-choice format. Participants’ responses were scored as
correct (coded as 1) or incorrect (0), and were then averaged for a knowledge score
(a = .70).
Treatment openness
At Time 2, participants answered six questions related to their openness to potential
treatments if they should receive a cancer diagnosis. Participantswere told, ‘Although you
may not have cancer, we would like to knowwhat treatment you think you might have if
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you were to have prostate cancer’. Participants were then presented with a list of
treatments (surgery, external beam radiation, brachytherapy, watchful waiting, adjuvant
hormone therapy, and experimental therapies such as cryotherapy) and answered yes
(coded as 1) or no (0) to each treatment. Participants could select ‘yes’ to multiple
treatments, and they could decline to answer.
Analytic strategy
The following analyses were conducted for both intrusive thoughts and test-result
anxiety. To examine change in anxiety from Time 1 to Time 2, we used general linear
model repeated-measures analysis of variance (ANOVA) with Time as a within-subjects
factor with two levels: Time 1 intrusive thoughts/test-result anxiety and Time 2 intrusive
thoughts/test-result anxiety. To examine associations with knowledge, we first examined
the bivariate correlations between the anxiety measures and knowledge. We then
conducted hierarchical linear regressions in which Time 1 anxiety was entered in Step 1
and Time 2 anxiety was entered in Step 2. Because this analysis tests the ability of the
residuals of anxiety at Time 2 in predicting knowledge, it may be interpreted as an
association between change in anxiety and knowledge (Cohen, Cohen, West, & Aiken,
2003). Analyses followed the same method of entry to examine associations with
openness to treatment variables except logistic regression was used because these
variables were coded dichotomously. Logistic regression was also used to test
anxiety 9 knowledge interactions on openness to treatment variables.
Results
Descriptives
Descriptive analyses showed that, on average, participants answered about one-half of
the knowledge questions correctly (M = 0.52, SD = 0.27). Of treatment options,
participants were most open to surgery (42% said yes; SD = 0.50) and least open to
experimental therapies (21%; SD = 0.41). Approximately 39% of participants said ‘yes’
to only one treatment, 38% said ‘yes’ to more than one treatment (the majority of
these said ‘yes’ to two treatments), 15% said ‘no’ to all treatments, and the remaining
8% declined to answer.
Table 1 presents the correlations between intrusive thoughts and test-result anxiety at
Time 1 and Time 2, knowledge, and openness to treatments. Intrusive thoughts at Time 1
and Time 2 were significantly correlated, r = .71, p < .001, as was test-result anxiety at
Time 1 and Time 2, r = .45, p < .001.4 Not surprisingly, the twomeasures of anxietywere
positively correlated with each other at both time points. Both measures were negatively
associatedwith knowledge.While neither anxiety measure at Time 1was associated with
openness to the treatment options, both measures at Time 2 were positively associated
with openness to surgery. Time 2 test-result anxiety was also positively associated with
openness to experimental therapies.
4 To test formulticollinearity in knowledge analyses, we examined the variance inflation factors. The valueswere 1.00 and 1.25 for
test-result anxiety, and 1.00 and 2.03 for intrusive thoughts, suggesting no multicollinearity issue. For the analyses with treatment
options, we examined the two highest correlations and then conducted regressions in steps (first examining Time 1 as the only
predictor, and then adding Time 2) to see whether the standard errors changed significantly. The analyses showed no
multicollinearity issue.
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Primary analyses
Change in anxiety from Time 1 to Time 2
Repeated-measures ANOVAs were conducted to test whether participants’ reports of
anxiety at Time 2 increased from their reports of anxiety at Time 1. For intrusive thoughts,
results showed that participants reported greater symptoms at Time 2 (M = 1.11,
SD = 0.78) compared to Time 1 (M = 1.01, SD = 0.77), and this difference was
significant, F(1, 263) = 6.68, p = .01, d = .12. Test-result anxiety was also significantly
higher at Time 2 (M = 1.17, SD = 1.12) than Time 1 (M = 0.97, SD = 1.06), F
(1, 263) = 8.77, p = .003, d = .19. Together, these findings show that as participants
came closer to receiving their feedback, both their intrusive thoughts about cancer and
their anxiety about their test result significantly increased.
Association between anxiety and knowledge
We next used linear regression to examine whether Time 2 anxiety was associated with
knowledge, while controlling for Time 1 anxiety. Recall, we were testing the hypothesis
that higher anxiety would be associated with lower knowledge. Analyses showed that
Time 2 intrusive thoughts were significantly, negatively associated with knowledge,
b = .21, t(252) = 2.36, p = .02. This anxiety explained a significant proportion of
variance in knowledge, R2 = .06, change in F(1, 252) = 5.54, p = .02. The findings for
test-result anxiety were similar such that therewas a significant, negative associationwith
knowledge, b = .14, t(252) = 2.00, p < .05, and the change in variance was
significant, R2 = .05, change in F(1, 252) = 3.99, p < .05. Thus, across both measures,
higher anxiety right before learning one’s diagnosiswas associatedwith less knowledge of
the risks and benefits of the treatment options.
Association between anxiety and treatment openness
To test the hypothesis that an increase in anxiety would be associated with
openness to different types of treatments, logistic regressions were conducted for
the six treatments. Table 2 presents the regression coefficients for all of these
analyses. The findings revealed that higher intrusive thoughts and test-result anxiety
at Time 2 were significantly associated with greater openness to surgery. Higher test-
result anxiety was also significantly associated with greater openness to hormone
therapy, and marginally significantly associated with greater openness to experimen-
tal therapies.
Secondary analyses
Interactions of anxiety and knowledge on treatment openness
Logistic regressions were conducted to examinewhether anxiety (i.e., intrusive thoughts
or test result) and knowledge interacted to influence treatment openness. For these
analyses, we first computed a continuous change score of anxiety by subtracting Time 1
anxiety from Time 2 anxiety. We then centred these change scores and participants’
knowledge scores. To create the interaction terms, the centred anxiety change scores
weremultiplied by the centred knowledge scores. In Step 1of the regressions, the centred
anxiety and knowledge scores were entered, and in Step 2 of the regressions, the
interaction terms were entered.
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Analyses revealed that intrusive thoughts and knowledge did not interact to influence
any of the openness to treatment variables. However, test-result anxiety interacted with
knowledge to influence openness to three treatments: surgery, B = 1.70, OR = 0.18,
Table 2. Openness to treatments as a function of change in intrusive thoughts and test-result anxiety
Independent variables B SE Wald Sig Exp (B)
Openness to surgery
Time 1 intrusive thoughts 0.13 0.24 0.30 .59 0.88
Time 2 intrusive thoughts 0.63 0.24 7.16 .01 1.89**
Overall model 11.28 .00
Time 1 test-result anxiety 0.05 0.14 0.13 .72 0.95
Time 2 test-result anxiety 0.31 0.13 5.53 .02 1.36*
Overall model 6.23 .04
Openness to external beam radiation
Time 1 intrusive thoughts 0.06 0.23 0.06 .81 1.06
Time 2 intrusive thoughts 0.13 0.23 0.32 .57 1.14
Overall model 1.15 .56
Time 1 test-result anxiety 0.07 0.14 0.29 .59 0.93
Time 2 test-result anxiety 0.18 0.13 1.90 .17 1.20
Overall model 1.91 .38
Openness to brachytherapy
Time 1 intrusive thoughts 0.03 0.24 0.02 .90 1.03
Time 2 intrusive thoughts 0.10 0.24 0.19 .67 1.11
Overall Model 0.56 .76
Time 1 test-result anxiety 0.04 0.14 0.08 .78 0.96
Time 2 test-result anxiety 0.10 0.14 0.51 .48 1.10
Overall model 0.51 .78
Openness to hormone therapy
Time 1 intrusive thoughts 0.03 0.27 0.01 .91 0.97
Time 2 intrusive thoughts 0.33 0.27 1.51 .22 1.39
Overall model 2.72 .26
Time 1 test-result anxiety 0.32 0.17 3.76 .05 0.72
Time 2 test-result anxiety 0.37 0.16 5.64 .02 1.44**
Overall model 6.83 .03
Openness to watchful waiting
Time 1 intrusive thoughts 0.04 0.24 0.02 .88 1.04
Time 2 intrusive thoughts 0.21 0.24 0.75 .39 0.82
Overall model 1.19 .55
Time 1 test-result anxiety 0.05 0.14 0.13 .72 1.05
Time 2 test-result anxiety 0.16 0.13 1.43 .23 0.85
Overall model 1.48 .48
Openness to experimental therapies
Time 1 intrusive thoughts 0.27 0.28 0.95 .33 1.31
Time 2 intrusive thoughts 0.02 0.28 0.00 .96 0.98
Overall model 1.78 .41
Time 1 test-result anxiety 0.04 0.16 0.06 .80 0.96
Time 2 test-result anxiety 0.31 0.16 3.77 .05 1.36†
Overall model 4.28 .12
Note. All Time 2 statistics control for Time 1.
*p < .05; **p < .01; †p < .10.
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p = .003, experimental therapies, B = 1.31, OR = 0.27, p = .03, and radiation,
B = 0.99, OR = 0.37, p = .04. Figures 1–3 present the graphs of these interactions.
The pattern was similar across the three openness variables: When participants showed
little to no increases in anxiety from Time 1 to Time 2, having low knowledge relative to
high knowledgewas associatedwith beingmore open to each treatment. However, when
participants showed high increases in anxiety across the time points, having low or high
knowledge was less likely to show these differences in openness.
Discussion
In the present study, men’s symptoms of anxiety increased as they came closer to
receiving feedback of whether they had prostate cancer. Higher anxiety was significantly
associated with less knowledge about prostate cancer and greater openness to particular
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Figure 1. Test-result anxiety 9 Knowledgeonopenness to surgery (with higher numbers representing
greater openness).Note that ‘low increase in anxiety’ represents little to no increase in anxiety aswell as a
decrease from Time 1 to Time 2.
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Figure 2. Test-result anxiety 9 Knowledge on openness to experimental therapies (with higher
numbers representing greater openness).
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treatments like surgery. Secondary analyses further showed that anxiety interacted with
knowledge in associations with openness to the different treatments. These findings
provide insight into the trajectory of anxiety as well its associations as individuals wait for
serious health feedback.
From the time they first presented for their prostate biopsy to the time, about 1 month
later, when they returned to learn their results, men increased in self-reported anxiety.
Although the overall increase was small, it was significant across twomeasures of anxiety
including intrusive thoughts about prostate cancer and anxiety about the test result.
Because normative prevalence data of anxiety symptoms inmen at-risk for prostate cancer
do not exist (Dale et al., 2005), it is difficult to determine how ‘normal’ the levels of
symptoms in our participantswere. In fact, our findings not only contribute to a small area
of research but also to an area of mixed results: To date, studies have found evidence of
both low and high anxiety in men undergoing prostate cancer screening (e.g., Carlsson
et al., 2007; Dale et al., 2005). Our findings show that anxiety may change while waiting
for a diagnosis, suggesting it is important to measure symptoms at more than one time
point during the screening process.
At both time points and across two measures, higher anxiety was significantly
correlated with less knowledge. Higher order analyses then showed that increased
anxiety symptomswere significantly associated with lower knowledge. These findings fit
with previous experimental research showing that negative affective states lead to less
attention and comprehension of information (e.g., Raghunathan & Pham, 1999). Given
this previous work, one interpretation of our study’s findings is that anxiety led
participants to pay less attention to the information in the decision aid. This interpretation
would also fit with theoretical perspectives that suggest that negative affect biases
information processing in predictable ways. For example, according to the affect as a
spotlight model (Peters, Lipkus, & Diefenbach, 2006), when individuals are making a
health decision, their anxiety about different options acts as a spotlight, leading them to
give greater attention to some information and less attention to other information. This
selective processing ultimately favours the option the individual has the least anxiety
about. While this theory and research may support the idea that anxiety inhibited
information processing, our study was correlational. Thus, alternative interpretations
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Figure 3. Test-result anxiety 9 Knowledge on openness to radiation (with higher numbers repre-
senting greater openness).
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cannot be ruled out. For example, one possibility is that having lower knowledge caused
anxiety. Although all participants reported reading the decision aid, some may not have
given it their complete attention or had difficulty understanding the information. Then,
because of their low knowledge, they increased in anxiety.
Increased anxiety was also associated with greater openness to the treatments of
surgery, hormone therapy, and experimental therapies. Because in prostate cancer
treatment decisions, there is no best treatment, these associations are difficult to
interpret. It could be that higher anxiety increased openness to treatments like surgery
and experimental therapies because these treatments are perceived as action-oriented
(e.g., Chapple et al., 2002). While the converse association with watchful waiting was
consistent with this idea, it was not significant. Although interpreting these
associations requires further research, the findings are meaningful if only to show
that anxiety during this time period is related to treatment openness. To the extent that
this openness leads to preferences, actual treatment decisions could be affected (e.g.,
Denberg et al., 2006).
Some of the associations above were qualified by interactions. For example, when
participants’ anxiety about their test result showed little to no increase from Time 1 to
Time 2, having high knowledge was associated with being less open to the different
treatments. However, when they increased in anxiety from Time 1 to Time 2, having
higher or lower knowledge was not distinctly related to openness. While these findings
are consistent with interactions found in other studies of cancer anxiety, knowledge,
and behaviour (Cameron & Reeve, 2006; Dillard et al., 2013), the present study is the
first to show this interaction in the context of prostate cancer. Together, these studies
suggest that cancer anxiety may motivate behaviour, but not through increased
knowledge.
Implications and future directions
Ourfinding that anxiety increased as individuals camecloser to receiving feedback about a
cancer diagnosis replicates one study in the area of prostate cancer (e.g., Zisman et al.,
2001) and several in the area of breast cancer (e.g., Benedict, Williams, & Baron, 1994;
Keyzer-Dekker, de Vries, Mertens, Roukema, & van der Steeg, 2014; Lang, Berbaum, &
Lutgendorf, 2009; Lang et al., 2006; Liao et al., 2008). Some researchers have
recommended shortening the anticipation period between biopsy and result disclosure.
In further showing that anxiety at this timemay be associated with worse knowledge, the
present study strengthens this recommendation.
One question for future research is why was knowledge negatively associated with
openness to all of the treatments except watchful waiting? These associations could
possibly indicate a general relationship between knowledge and preference for
treatments. For example, it is possible that people who are more knowledgeable feel
more comfortable taking a ‘wait and see’ approach while those with less knowledge are
more eager to have action-oriented treatment. Familiarity may also play a role in these
associations. A treatment like surgerymay seem familiar to people and thereby thosewith
less knowledge are more open to that treatment.
To provide more insight into anxiety’s relationship with knowledge, future studies
should integrate more comprehensive measures. Amount of effort used to learn
information might be one such measure. Also, assessing knowledge at multiple time
points may provide insight as to when anxiety influences knowledge (e.g., during initial
information processing or recall of information, or both?).
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Limitations
The correlational design of the present study is a limitation, and future research should
attempt to determine the causal direction of the observed associations. One caveat is that
true experimental designs in contexts similar to the present study may be difficult or
impossible. For example, as people wait for a cancer diagnosis, it may not be ethical to
randomly assign them to have more versus less knowledge to then determine the effects
on anxiety. Similarly, this time period is not one in which researchers would want to
increase anxiety to then determine what happens to information processing. However,
experimental research in a hypothetical cancer feedback context could shed light on our
correlational findings.
Another limitation related to the correlational design is that unmeasured variables
could have played a role in our findings. For example, we did not measure trait anxiety
which can relate to anxiety about cancer and information processing (Bar-Haim, Lamy,
Pergamin, Bakermans-Kranenburg, & van IJzendoorn, 2007; Keyzer-Dekker et al., 2014).
Conclusion
In the present study, asmenwaited for a prostate cancer diagnosis, they increased in both
intrusive thoughts about prostate cancer and anxiety about their test result. Increased
anxiety was associated with lower knowledge and more openness to particular
treatments. Some of these associations were qualified by interactions showing that when
anxiety increased, knowledge was not systematically connected to treatment openness.
This study highlights the need for more research on specific negative emotions and their
implications in individuals waiting for diagnoses.
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